<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03219996</url>
  </required_header>
  <id_info>
    <org_study_id>myocarditis20161226</org_study_id>
    <nct_id>NCT03219996</nct_id>
  </id_info>
  <brief_title>Risk Factors for Predictors of In-hospital Death in Acute Fulminant Myocarditis</brief_title>
  <official_title>Risk Factors Influenced Prognosis of Acute Fulminant Myocarditis by Analyzing Clinical Characteristics and Complications, Laboratory Findings, Treatments, and Electrocardiographic and Echocardiographic Data.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The First Affiliated Hospital of Soochow University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The First Affiliated Hospital of Soochow University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators performed a retrospective, single-center observational study, and the
      participants with acute fulminant myocarditis were included.Then, the investigator analyzed
      the risk factors of in-hospital death in these participants with acute fulminant myocarditis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2016</start_date>
  <completion_date type="Actual">December 30, 2016</completion_date>
  <primary_completion_date type="Actual">December 30, 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Renal Impairment Influence Prognosis of Acute Fulminant Myocarditis</measure>
    <time_frame>2017-01-30</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">76</enrollment>
  <condition>Viral Myocarditis</condition>
  <condition>Cardio-Renal Syndrome</condition>
  <condition>Risk Factor, Cardiovascular</condition>
  <arm_group>
    <arm_group_label>non-survivor group</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>survivor group</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>prognosis</intervention_name>
    <description>The participants were divided into two groups based on survival at their hospital discharge.</description>
    <arm_group_label>non-survivor group</arm_group_label>
    <arm_group_label>survivor group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The definition of a fulminant acute myocarditis was the presence of a rapid onset of
        aggressive life-threatening disease accompanied by cardiogenic shock with multiple organ
        dysfunction syndrome, acute severe heart failure, fatal arrhythmias, high-degree
        atrioventricular blockade, or sudden cardiac death following a flu-like illness.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Clinical diagnosis of acute fulminant myocarditis

        Exclusion Criteria:

        chronic renal dysfunction refuse medical treatments
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xiangjun Yang, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>First Affiliated Hospital of Soochow University</affiliation>
  </overall_official>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 4, 2017</study_first_submitted>
  <study_first_submitted_qc>July 14, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 18, 2017</study_first_posted>
  <last_update_submitted>July 14, 2017</last_update_submitted>
  <last_update_submitted_qc>July 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocarditis</mesh_term>
    <mesh_term>Cardio-Renal Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

